Day: July 8, 2021

Picture 1Figure 1VANCOUVER, British Columbia and IRVINE, Calif., July 08, 2021 (GLOBE NEWSWIRE) — PowerTap Hydrogen Capital Corp. (NEO: MOVE)(FWB: 2K6)(OTC: MOTNF) (“PowerTap” or the “Company” or “MOVE”) is pleased to announce that its wholly-owned subsidiary, PowerTap Hydrogen Fueling Corp. (“PowerTap Fueling”) has completed the engineering design of the PowerTap Gen3 making significant improvements in its steam methane reformer (SMR) that increases the production of hydrogen, reduces feedstock requirements, and extends the life of the SMR. The design of the SMR remains subject to revisions, pending the successful manufacturing of a prototype that achieves all of the functionalities as intended. The diagram below illustrates the current design of the SMR. Specific innovations include:The improvement...

WASHINGTON, July 08, 2021 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that it will release financial results for the second quarter ended June 30, 2021, before the New York market opens on Thursday, July 29, 2021. A conference call will be held to discuss these financial results on Thursday, July 29, 2021, at 9:00 a.m. Eastern Time and will be hosted by senior management. The conference call will be simulcast live on the Internet and can be accessed by logging onto the Company’s investor relations website. A replay of the webcast will be available on the Company’s investor relations website for 90 days. About FTI ConsultingFTI Consulting, Inc. is a global business advisory firm dedicated to helping organizations manage change, mitigate risk and resolve disputes: financial, legal, operational, political &...

Dallas, July 08, 2021 (GLOBE NEWSWIRE) — Thryv Holdings, Inc. (NASDAQ:THRY), the provider of Thryv® software, the end-to-end client experience platform for small businesses, today announced it has ranked on the Selling Power 50 Best Companies to Sell For 2021 list for the fifth consecutive year. Improving its ranking year over year, Thryv nabbed the 11th spot on this year’s list—which has been published for its 21st consecutive year. Each year, the corporate research team at Selling Power magazine assembles and publishes its list of the 50 Best Companies to Sell For. The list encompasses companies of all sizes, with sales forces ranging from fewer than 100 salespeople to companies with sales-force numbers in the thousands. Our primary goal at Thryv is to help small businesses succeed. That mission was more amplified this past year...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG, SINGAPORE OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. FURTHER RESTRICTIONS ARE APPLICABLE, AS DESCRIBED IN THE ATTACHED BUY-BACK OFFER DOCUMENT. Reference is made to the stock exchange notification published by Electromagnetic Geoservices ASA (“EMGS” or the “Company”) on 7 July 2021 wherein the Company announced its intention to launch a voluntary, partial buy-back of bonds with an aggregate principal amount of up to USD 4,000,000 under the Company’s outstanding bond issue FRN Electromagnetic Geoservices ASA Senior Unsecured Convertible USD 32,500,000 Bonds 2018/2023. EMGS has today published the attached Buy-Back Offer...

BROOKFIELD, NEWS, July 08, 2021 (GLOBE NEWSWIRE) — Brookfield Infrastructure Partners L.P. (NYSE: BIP; TSX: BIP.UN) and Brookfield Infrastructure Corporation (NYSE: BIPC; TSX: BIPC) (collectively “Brookfield Infrastructure”) today announced they are initiating a voluntary sale program (the “Program”) through which eligible holders of BIP limited partnership units and/or BIPC class A exchangeable subordinate voting shares (collectively the “Odd Lot Securities”) may conveniently sell their Odd Lot Securities. The program benefits securityholders who held fewer than 100 Odd Lot Securities, as of July 7, 2021, being the record date in respect of the Program, and want to sell their Odd Lot Securities without paying brokerage commissions, thereby avoiding having to incur fees that could represent a material percentage of their proceeds....

TEL AVIV, Israel, July 08, 2021 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT) today announced the appointments of Alison Finger and Michael Rice to its Board of Directors, effective July 7, 2021. Professor Ruth Arnon has stepped down from her role as a member of VBL’s Board of Directors, effective July 6, 2021. She will continue her engagement with VBL as a scientific consultant and a member of its Scientific Advisory Board. “We are pleased to welcome Alison and Michael as the newest members of our Board of Directors,” said Bennett Shapiro, M.D., Chairman of VBL’s Board of Directors. “Alison’s extensive experience commercializing products globally at bluebird bio and Bristol-Myers Squibb and Michael’s expertise in healthcare capital markets will be invaluable to us as we approach disclosure of topline data from the OVAL clinical...

LONDON, July 08, 2021 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its second quarter 2021 financial results and operational highlights before open of U.S. markets on Thursday, August 5, 2021. Management will host a conference call and webcast at 8:30 am EDT/1:30 pm GMT to discuss the company’s financial results and provide a general business update. To listen to the webcast and view the accompanying slide presentation, please go to the events section of Autolus’ website. The call may also be accessed by dialing (866) 679-5407 for U.S. and Canada callers or (409) 217-8320 for international callers. Please reference conference ID 9757293. After the conference call, a replay will be...

Piraeus, Greece, July 08, 2021 (GLOBE NEWSWIRE) — GasLog Partners LP (“GasLog Partners” or the “Partnership”)(NYSE: GLOP) today announced senior management and board of director changes. The board of directors of GasLog Partners (the “Board”) is pleased to appoint Paolo Enoizi, currently Chief Operating Officer (“COO”) of the Partnership’s General Partner, GasLog Ltd. (“GasLog” and together with GasLog Partners, the “Group”), and GasLog Partners, as Chief Executive Officer (“CEO”) of the Partnership, effective August 1, 2021. Mr. Enoizi will continue to serve as COO of GasLog and GasLog Partners following his appointment as CEO of GasLog Partners. Paul Wogan will step down from his position as the Partnership’s CEO on July 31, 2021; however, he will remain CEO of GasLog. In addition, GasLog Partners announced...

BOSTON, July 08, 2021 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology company focused on developing therapies targeting key signaling pathways that drive the formation and spread of cancer, today announced that Dr. Mark Manfredi, CEO of Ikena Oncology, will participate in a panel discussing next-generation approaches to targeted oncology at the upcoming virtual William Blair Biotech Focus Conference. Details on the panel webcast can be found below.         Date: Thursday, July 15, 2021        Time: 9:00 – 9:45 a.m. ET        Webcast Link: Register The panel will be webcast live and can be accessed by visiting the Investors & Media section of the company’s website at www.ikenaoncology.com. The webcast will be archived for a period of 30 days following the conclusion of the live event. About Ikena...

Brings 25 years of strategic leadership experience across healthcare CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Denice Torres will join the company’s board of directors. Ms. Torres has over 25 years of executive leadership experience in healthcare across the consumer, biopharmaceutical and medical device sectors. “I am thrilled to welcome Denice to the Surface board. She shares our commitment to bring transformational treatments to patients living with cancer,” said Rob Ross, M.D., chief executive officer at Surface. “She is an insightful leader in biopharma, with significant experience in leading companies through critical growth periods. In addition,...